Peer Review Policy

The Journal of Medical and Clinical Innovations  follows a rigorous and transparent peer-review process to ensure the publication of high-quality, original, and clinically relevant research in medicine and healthcare.

All submitted manuscripts undergo an initial editorial screening to assess relevance to the journal scope, originality, and basic scientific quality. Manuscripts that meet the minimum requirements are forwarded for external peer review.

The journal follows a double-blind peer-review system, where both authors and reviewers remain anonymous throughout the review process. This ensures objectivity, reduces bias, and promotes fair evaluation of all submissions.

Each manuscript is typically reviewed by at least two independent experts with relevant expertise in clinical medicine, biomedical sciences, or related healthcare fields.

Reviewers evaluate submissions based on:

• Originality and scientific contribution

• Clinical relevance and applicability

• Methodological and experimental rigor

• Accuracy of data analysis and interpretation

• Ethical compliance in research conduct

• Clarity, structure, and presentation quality

• Proper use of references and academic integrity

Based on reviewer recommendations, the editorial board may decide to:

• Accept the manuscript without revision

• Accept with minor revisions

• Request major revisions and resubmission

• Reject the manuscript

Authors are expected to respond carefully to reviewer comments and resubmit revised manuscripts within the given timeframe. Revised submissions may undergo additional review before final acceptance.

All peer-review activities are conducted under strict confidentiality. Reviewers must not share, disclose, or use unpublished information obtained during the review process.

The Journal of Medical and Clinical Innovations is committed to maintaining a fair, unbiased, and high-quality peer-review system that supports excellence in medical research and clinical practice.